Théo is a Principal operating from Canada who joined Theodorus in 2018 to help with the screening, assessment, and execution of investment opportunities. He has previously grown his expertise in strategy and due diligence for private equity and industrial clients at Roland Berger. Théo has led several transactions for Theodorus in Europe and Canada, and holds seats at the board of several life sciences and deep-tech companies. He is a prominent figure, for example, at: Calyos, Kaspard, Icentia, Classcraft, DrugBank and Domain Therapeutics. Théo holds a dual Master’s Degree in Finance and in Quantitative Techniques (QTEM) from the Solvay Brussels School of Economics and Management.